AC
AVNS

Alexandria Capital’s Avanos Medical AVNS Stock Holding History

Alexandria Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-31
Closed -$1K – 257
2017
Q3 		$1K Hold
31
– – ﹤0.01% 524
2017
Q2 		$1K Hold
31
– – ﹤0.01% 579
2017
Q1 		$1K Hold
31
– – ﹤0.01% 576
2016
Q4 		$1K Hold
31
– – ﹤0.01% 556
2016
Q3 		$1K Hold
31
– – ﹤0.01% 567
2016
Q2 		$1K Hold
31
– – ﹤0.01% 564
2016
Q1 		$1K Hold
31
– – ﹤0.01% 570
2015
Q4 		$1K Hold
31
– – ﹤0.01% 615
2015
Q3 		$1K Sell
31
-232
-88% -$8.09K ﹤0.01% 560
2015
Q2 		$11K Hold
263
– – ﹤0.01% 405
2015
Q1 		$13K Hold
263
– – ﹤0.01% 356
2014
Q4 		$12K Buy
+263
New +$10.3K ﹤0.01% 338

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alexandria Capital's AVNS Position: Q4 2017 in Review

Alexandria Capital sold out of Avanos Medical (AVNS) in Q4 2017, closing a stake of 31 shares — an estimated $1K sold.

Alexandria Capital first reported a position in AVNS in Q4 2014 and held it in 12 quarters. The position peaked at $13K in Q1 2015. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2017.

  • Alexandria Capital reported no remaining Avanos Medical position as of Q4 2017 after selling out during the quarter.
  • Alexandria Capital sold 31 Avanos Medical shares in Q4 2017, an estimated $1K.
  • Alexandria Capital first reported a position in Avanos Medical in Q4 2014 and held it in 12 quarters.
  • Alexandria Capital's Avanos Medical position peaked at $13K in Q1 2015.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2017.

Based on Alexandria Capital's 13F filing for Q4 2017, filed 9 Feb 2018.